|
|
Volumn 271, Issue 5256, 1996, Pages 1691-1692
|
|
Releasing the brakes on antitumor immune response
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER VACCINE;
CD28 ANTIGEN;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;
MAJOR HISTOCOMPATIBILITY ANTIGEN;
T LYMPHOCYTE RECEPTOR;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTINEOPLASTIC ACTIVITY;
CANCER IMMUNOTHERAPY;
HUMAN;
IMMUNE RESPONSE;
MOUSE;
NATURAL KILLER CELL;
NONHUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
T LYMPHOCYTE ACTIVATION;
TUMOR IMMUNITY;
ANIMALS;
ANTIBODIES;
ANTIGENS, CD;
ANTIGENS, DIFFERENTIATION;
HUMANS;
IMMUNOCONJUGATES;
IMMUNOTHERAPY;
LYMPHOCYTE ACTIVATION;
MICE;
NEOPLASMS;
T-LYMPHOCYTES;
VACCINES;
ANIMALIA;
|
|
EID: 0029974509
PISSN: 00368075
EISSN: None
Source Type: Journal
DOI: 10.1126/science.271.5256.1691 Document Type: Short Survey |
|
Times cited : (16)
|
|
References (0)
|
